

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of mitochondrial translation (GO:0070129) | 7.40035571 |
| 2 | adaptation of signaling pathway (GO:0023058) | 7.02232534 |
| 3 | base-excision repair, AP site formation (GO:0006285) | 6.42966569 |
| 4 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 6.30605937 |
| 5 | regulation of fatty acid beta-oxidation (GO:0031998) | 6.24122300 |
| 6 | pseudouridine synthesis (GO:0001522) | 5.74763000 |
| 7 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 5.60730671 |
| 8 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 5.47047949 |
| 9 | negative regulation of membrane potential (GO:0045837) | 5.45007041 |
| 10 | positive regulation of endothelial cell differentiation (GO:0045603) | 5.44004973 |
| 11 | water-soluble vitamin biosynthetic process (GO:0042364) | 5.38182105 |
| 12 | protein K48-linked deubiquitination (GO:0071108) | 5.21985702 |
| 13 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 5.08816128 |
| 14 | kidney mesenchyme development (GO:0072074) | 4.86431871 |
| 15 | pyrimidine nucleotide catabolic process (GO:0006244) | 4.79955693 |
| 16 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 4.74758246 |
| 17 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 4.69400067 |
| 18 | histone deubiquitination (GO:0016578) | 4.54706023 |
| 19 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.54650142 |
| 20 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 4.54329328 |
| 21 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 4.26829310 |
| 22 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 4.24207734 |
| 23 | cysteine metabolic process (GO:0006534) | 4.16043768 |
| 24 | protein complex biogenesis (GO:0070271) | 4.10107118 |
| 25 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 3.85544710 |
| 26 | histone H2A monoubiquitination (GO:0035518) | 3.74227260 |
| 27 | protein localization to peroxisome (GO:0072662) | 3.71626932 |
| 28 | protein targeting to peroxisome (GO:0006625) | 3.71626932 |
| 29 | establishment of protein localization to peroxisome (GO:0072663) | 3.71626932 |
| 30 | mitochondrial RNA metabolic process (GO:0000959) | 3.64903340 |
| 31 | lung secretory cell differentiation (GO:0061140) | 3.64274709 |
| 32 | protein import into peroxisome matrix (GO:0016558) | 3.63916963 |
| 33 | positive regulation of fatty acid oxidation (GO:0046321) | 3.63422133 |
| 34 | adenine nucleotide transport (GO:0051503) | 3.62882146 |
| 35 | L-serine transport (GO:0015825) | 3.59291218 |
| 36 | peroxisomal transport (GO:0043574) | 3.53081146 |
| 37 | serine transport (GO:0032329) | 3.50564222 |
| 38 | regulation of endothelial cell differentiation (GO:0045601) | 3.50192693 |
| 39 | purine ribonucleotide transport (GO:0015868) | 3.40516236 |
| 40 | vitamin biosynthetic process (GO:0009110) | 3.38390183 |
| 41 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 3.35838300 |
| 42 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.35324299 |
| 43 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 3.35078327 |
| 44 | deoxyribonucleotide catabolic process (GO:0009264) | 3.33666735 |
| 45 | protein neddylation (GO:0045116) | 3.32719067 |
| 46 | dopaminergic neuron differentiation (GO:0071542) | 3.31504052 |
| 47 | cobalamin metabolic process (GO:0009235) | 3.21506307 |
| 48 | negative regulation of cell aging (GO:0090344) | 3.21244331 |
| 49 | pattern specification involved in kidney development (GO:0061004) | 3.18723040 |
| 50 | deoxyribose phosphate catabolic process (GO:0046386) | 3.14187124 |
| 51 | protein-cofactor linkage (GO:0018065) | 3.10548466 |
| 52 | response to gravity (GO:0009629) | 3.07402302 |
| 53 | behavioral response to nicotine (GO:0035095) | 3.06539935 |
| 54 | regulation of activin receptor signaling pathway (GO:0032925) | 3.05575451 |
| 55 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.01010137 |
| 56 | metanephric mesenchyme development (GO:0072075) | 2.98195461 |
| 57 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.96097911 |
| 58 | positive regulation of histone deacetylation (GO:0031065) | 2.96020648 |
| 59 | transcription from mitochondrial promoter (GO:0006390) | 2.93057533 |
| 60 | embryonic skeletal joint morphogenesis (GO:0060272) | 2.88528084 |
| 61 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2 | 2.88171468 |
| 62 | regulation of histone phosphorylation (GO:0033127) | 2.87120458 |
| 63 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.86560137 |
| 64 | primary amino compound metabolic process (GO:1901160) | 2.86136816 |
| 65 | serotonin metabolic process (GO:0042428) | 2.85875247 |
| 66 | cholesterol biosynthetic process (GO:0006695) | 2.83046612 |
| 67 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.80278598 |
| 68 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.80278598 |
| 69 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.78103384 |
| 70 | L-phenylalanine metabolic process (GO:0006558) | 2.78103384 |
| 71 | positive regulation of receptor biosynthetic process (GO:0010870) | 2.77976125 |
| 72 | purine nucleotide transport (GO:0015865) | 2.75661318 |
| 73 | histone H2A ubiquitination (GO:0033522) | 2.75219306 |
| 74 | regulation of translational fidelity (GO:0006450) | 2.75173522 |
| 75 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.72458714 |
| 76 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.72239242 |
| 77 | retinal ganglion cell axon guidance (GO:0031290) | 2.65748362 |
| 78 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.65381047 |
| 79 | maturation of 5.8S rRNA (GO:0000460) | 2.64196459 |
| 80 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.62785666 |
| 81 | regulation of cardioblast proliferation (GO:0003264) | 2.62785666 |
| 82 | regulation of sequestering of triglyceride (GO:0010889) | 2.62098524 |
| 83 | sulfur amino acid catabolic process (GO:0000098) | 2.61608617 |
| 84 | sequestering of actin monomers (GO:0042989) | 2.61499090 |
| 85 | resolution of meiotic recombination intermediates (GO:0000712) | 2.61323869 |
| 86 | cochlea morphogenesis (GO:0090103) | 2.60948887 |
| 87 | L-phenylalanine catabolic process (GO:0006559) | 2.60267760 |
| 88 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.60267760 |
| 89 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.60144805 |
| 90 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.60144805 |
| 91 | NADH dehydrogenase complex assembly (GO:0010257) | 2.60144805 |
| 92 | negative regulation of phagocytosis (GO:0050765) | 2.60089406 |
| 93 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.60023970 |
| 94 | regulation of fatty acid oxidation (GO:0046320) | 2.58743716 |
| 95 | cytochrome complex assembly (GO:0017004) | 2.57599267 |
| 96 | activation of MAPKKK activity (GO:0000185) | 2.54753407 |
| 97 | homocysteine metabolic process (GO:0050667) | 2.52347584 |
| 98 | tRNA methylation (GO:0030488) | 2.52135356 |
| 99 | establishment of planar polarity (GO:0001736) | 2.51297740 |
| 100 | monoubiquitinated protein deubiquitination (GO:0035520) | 12.5414112 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.75858037 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.59765440 |
| 3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.44258207 |
| 4 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.39569434 |
| 5 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 2.91108424 |
| 6 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.81490267 |
| 7 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.64033716 |
| 8 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.62739011 |
| 9 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.60002818 |
| 10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.59041284 |
| 11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.50912246 |
| 12 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.50073154 |
| 13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.49653743 |
| 14 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.48290230 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 2.38032886 |
| 16 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.26364682 |
| 17 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.08900314 |
| 18 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.08069376 |
| 19 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.07618518 |
| 20 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.07233539 |
| 21 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.06316792 |
| 22 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.06185358 |
| 23 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.02395381 |
| 24 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.01862876 |
| 25 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.98023498 |
| 26 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.95716861 |
| 27 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.94176898 |
| 28 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.92599389 |
| 29 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.91937904 |
| 30 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.87829570 |
| 31 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.85546191 |
| 32 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.83781860 |
| 33 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.82138802 |
| 34 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.76053188 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.74973677 |
| 36 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.71706670 |
| 37 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.68592056 |
| 38 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.68194086 |
| 39 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.64697960 |
| 40 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.63824129 |
| 41 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.63600499 |
| 42 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.61668357 |
| 43 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.60983746 |
| 44 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.57777620 |
| 45 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.57657633 |
| 46 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.55120414 |
| 47 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.54026134 |
| 48 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.53357854 |
| 49 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.47191017 |
| 50 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.46489816 |
| 51 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.45752736 |
| 52 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.45379069 |
| 53 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.40012359 |
| 54 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.39927493 |
| 55 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.38623490 |
| 56 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.38112849 |
| 57 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.36813253 |
| 58 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.36107318 |
| 59 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.35851181 |
| 60 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.32384307 |
| 61 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.31786076 |
| 62 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.29667181 |
| 63 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.27119910 |
| 64 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.24831147 |
| 65 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.24180965 |
| 66 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.24007107 |
| 67 | P68_20966046_ChIP-Seq_HELA_Human | 1.22200041 |
| 68 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.22076810 |
| 69 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.20805777 |
| 70 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.20787893 |
| 71 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.16989750 |
| 72 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.16526310 |
| 73 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.15652654 |
| 74 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.14569492 |
| 75 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.14132209 |
| 76 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.12782370 |
| 77 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.12036975 |
| 78 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.11537481 |
| 79 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.09739571 |
| 80 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.09524840 |
| 81 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.08580581 |
| 82 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.06336978 |
| 83 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.05328885 |
| 84 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.04580532 |
| 85 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.03640032 |
| 86 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.03230498 |
| 87 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.02671132 |
| 88 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.02608085 |
| 89 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02331873 |
| 90 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.98585496 |
| 91 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.97591451 |
| 92 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.97486784 |
| 93 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.95629952 |
| 94 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.94299881 |
| 95 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.94239825 |
| 96 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.93011933 |
| 97 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.91709119 |
| 98 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.91347398 |
| 99 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90564341 |
| 100 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.89816902 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 7.87345066 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 4.65746214 |
| 3 | MP0003122_maternal_imprinting | 4.54827371 |
| 4 | MP0002736_abnormal_nociception_after | 4.08509867 |
| 5 | MP0003011_delayed_dark_adaptation | 3.15668464 |
| 6 | MP0004185_abnormal_adipocyte_glucose | 2.85949695 |
| 7 | MP0000537_abnormal_urethra_morphology | 2.84877831 |
| 8 | MP0003123_paternal_imprinting | 2.77094805 |
| 9 | MP0001905_abnormal_dopamine_level | 2.60781495 |
| 10 | MP0001529_abnormal_vocalization | 2.59984746 |
| 11 | MP0004742_abnormal_vestibular_system | 2.51797678 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.51053823 |
| 13 | MP0003121_genomic_imprinting | 2.45115065 |
| 14 | MP0005645_abnormal_hypothalamus_physiol | 2.30747882 |
| 15 | MP0003890_abnormal_embryonic-extraembry | 2.26349699 |
| 16 | MP0010030_abnormal_orbit_morphology | 2.25455425 |
| 17 | MP0002735_abnormal_chemical_nociception | 1.99480632 |
| 18 | MP0000534_abnormal_ureter_morphology | 1.94128770 |
| 19 | MP0005670_abnormal_white_adipose | 1.92305531 |
| 20 | MP0009384_cardiac_valve_regurgitation | 1.89888117 |
| 21 | MP0000049_abnormal_middle_ear | 1.84918689 |
| 22 | MP0001853_heart_inflammation | 1.83256452 |
| 23 | MP0004133_heterotaxia | 1.75452496 |
| 24 | MP0008775_abnormal_heart_ventricle | 1.73633051 |
| 25 | MP0001346_abnormal_lacrimal_gland | 1.64611012 |
| 26 | MP0003942_abnormal_urinary_system | 1.59220260 |
| 27 | MP0002249_abnormal_larynx_morphology | 1.56419132 |
| 28 | MP0000678_abnormal_parathyroid_gland | 1.55974125 |
| 29 | MP0001270_distended_abdomen | 1.53161083 |
| 30 | MP0001727_abnormal_embryo_implantation | 1.46221198 |
| 31 | MP0008789_abnormal_olfactory_epithelium | 1.43554625 |
| 32 | MP0005367_renal/urinary_system_phenotyp | 1.42262452 |
| 33 | MP0000516_abnormal_urinary_system | 1.42262452 |
| 34 | MP0000343_altered_response_to | 1.36772176 |
| 35 | MP0002277_abnormal_respiratory_mucosa | 1.32945455 |
| 36 | MP0010234_abnormal_vibrissa_follicle | 1.30126314 |
| 37 | MP0002102_abnormal_ear_morphology | 1.27805565 |
| 38 | MP0005666_abnormal_adipose_tissue | 1.24464634 |
| 39 | MP0001188_hyperpigmentation | 1.22450882 |
| 40 | MP0003755_abnormal_palate_morphology | 1.18720953 |
| 41 | MP0005058_abnormal_lysosome_morphology | 1.14804289 |
| 42 | MP0000751_myopathy | 1.13896566 |
| 43 | MP0001661_extended_life_span | 1.10849753 |
| 44 | MP0000778_abnormal_nervous_system | 1.10794571 |
| 45 | MP0002282_abnormal_trachea_morphology | 1.06024326 |
| 46 | MP0000026_abnormal_inner_ear | 1.02658369 |
| 47 | MP0001666_abnormal_nutrient_absorption | 1.01754670 |
| 48 | MP0003111_abnormal_nucleus_morphology | 1.01283804 |
| 49 | MP0002938_white_spotting | 0.97851864 |
| 50 | MP0003077_abnormal_cell_cycle | 0.97557021 |
| 51 | MP0000538_abnormal_urinary_bladder | 0.96843709 |
| 52 | MP0000681_abnormal_thyroid_gland | 0.95621098 |
| 53 | MP0003937_abnormal_limbs/digits/tail_de | 0.95359729 |
| 54 | MP0010094_abnormal_chromosome_stability | 0.95231179 |
| 55 | MP0002822_catalepsy | 0.94358160 |
| 56 | MP0005386_behavior/neurological_phenoty | 0.92966677 |
| 57 | MP0004924_abnormal_behavior | 0.92966677 |
| 58 | MP0002751_abnormal_autonomic_nervous | 0.88826858 |
| 59 | MP0009046_muscle_twitch | 0.87997948 |
| 60 | MP0003786_premature_aging | 0.78948228 |
| 61 | MP0008058_abnormal_DNA_repair | 0.78630005 |
| 62 | MP0004130_abnormal_muscle_cell | 0.78518835 |
| 63 | MP0002557_abnormal_social/conspecific_i | 0.78142542 |
| 64 | MP0004233_abnormal_muscle_weight | 0.77956820 |
| 65 | MP0003183_abnormal_peptide_metabolism | 0.74220395 |
| 66 | MP0009780_abnormal_chondrocyte_physiolo | 0.68361729 |
| 67 | MP0000631_abnormal_neuroendocrine_gland | 0.67758976 |
| 68 | MP0003938_abnormal_ear_development | 0.65829919 |
| 69 | MP0002116_abnormal_craniofacial_bone | 0.63578784 |
| 70 | MP0009764_decreased_sensitivity_to | 0.63549390 |
| 71 | MP0008875_abnormal_xenobiotic_pharmacok | 0.63330817 |
| 72 | MP0001340_abnormal_eyelid_morphology | 0.63203105 |
| 73 | MP0002932_abnormal_joint_morphology | 0.63114119 |
| 74 | MP0008007_abnormal_cellular_replicative | 0.62782428 |
| 75 | MP0005332_abnormal_amino_acid | 0.62392697 |
| 76 | MP0004782_abnormal_surfactant_physiolog | 0.61690586 |
| 77 | MP0002177_abnormal_outer_ear | 0.59596278 |
| 78 | MP0001963_abnormal_hearing_physiology | 0.59341212 |
| 79 | MP0001730_embryonic_growth_arrest | 0.54450932 |
| 80 | MP0003718_maternal_effect | 0.54008718 |
| 81 | MP0001502_abnormal_circadian_rhythm | 0.52687731 |
| 82 | MP0001849_ear_inflammation | 0.51746645 |
| 83 | MP0005220_abnormal_exocrine_pancreas | 0.51516249 |
| 84 | MP0003221_abnormal_cardiomyocyte_apopto | 0.51403207 |
| 85 | MP0002160_abnormal_reproductive_system | 0.51345644 |
| 86 | MP0009053_abnormal_anal_canal | 0.50621139 |
| 87 | MP0003699_abnormal_female_reproductive | 0.49389403 |
| 88 | MP0003329_amyloid_beta_deposits | 0.49351240 |
| 89 | MP0005410_abnormal_fertilization | 0.48926120 |
| 90 | MP0005266_abnormal_metabolism | 0.48857191 |
| 91 | MP0005375_adipose_tissue_phenotype | 0.47904437 |
| 92 | MP0002928_abnormal_bile_duct | 0.47166278 |
| 93 | MP0002272_abnormal_nervous_system | 0.47083585 |
| 94 | MP0002572_abnormal_emotion/affect_behav | 0.46518690 |
| 95 | MP0005408_hypopigmentation | 0.46027747 |
| 96 | MP0001944_abnormal_pancreas_morphology | 0.45328701 |
| 97 | MP0003693_abnormal_embryo_hatching | 0.44996273 |
| 98 | MP0003861_abnormal_nervous_system | 0.43580241 |
| 99 | MP0001324_abnormal_eye_pigmentation | 0.42691439 |
| 100 | MP0002067_abnormal_sensory_capabilities | 0.42107777 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Meningioma (HP:0002858) | 6.93630440 |
| 2 | Hyperglycinemia (HP:0002154) | 6.42434285 |
| 3 | Methylmalonic aciduria (HP:0012120) | 5.52856415 |
| 4 | Methylmalonic acidemia (HP:0002912) | 5.39913856 |
| 5 | Melanoma (HP:0002861) | 4.43064196 |
| 6 | Asymmetry of the thorax (HP:0001555) | 4.11353824 |
| 7 | Neoplasm of the lung (HP:0100526) | 3.53446644 |
| 8 | Lymphangioma (HP:0100764) | 3.49930820 |
| 9 | Benign neoplasm of the central nervous system (HP:0100835) | 3.34666227 |
| 10 | Neoplasm of the respiratory system (HP:0100606) | 3.26511282 |
| 11 | Abnormality of glycine metabolism (HP:0010895) | 3.23375058 |
| 12 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.23375058 |
| 13 | Small epiphyses (HP:0010585) | 3.08805311 |
| 14 | Progressive sensorineural hearing impairment (HP:0000408) | 3.00847099 |
| 15 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.93590356 |
| 16 | Dicarboxylic aciduria (HP:0003215) | 2.93590356 |
| 17 | Squamous cell carcinoma (HP:0002860) | 2.92072806 |
| 18 | Neonatal onset (HP:0003623) | 2.78313861 |
| 19 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.57847438 |
| 20 | Short nail (HP:0001799) | 2.54708868 |
| 21 | Back pain (HP:0003418) | 2.52836319 |
| 22 | Delayed epiphyseal ossification (HP:0002663) | 2.51382520 |
| 23 | Ulnar deviation of the wrist (HP:0003049) | 2.51303401 |
| 24 | Neoplasm of the adrenal gland (HP:0100631) | 2.48122909 |
| 25 | Ureteral duplication (HP:0000073) | 2.43163506 |
| 26 | Subacute progressive viral hepatitis (HP:0006572) | 2.42550665 |
| 27 | Amblyopia (HP:0000646) | 2.29489580 |
| 28 | Anxiety (HP:0000739) | 2.26284928 |
| 29 | Abnormality of vitamin B metabolism (HP:0004340) | 2.21538176 |
| 30 | Congenital, generalized hypertrichosis (HP:0004540) | 2.21157424 |
| 31 | Rough bone trabeculation (HP:0100670) | 2.19821271 |
| 32 | Abdominal distention (HP:0003270) | 2.16149714 |
| 33 | Neoplasm of the adrenal cortex (HP:0100641) | 2.14508087 |
| 34 | Torticollis (HP:0000473) | 2.13609379 |
| 35 | Sparse eyelashes (HP:0000653) | 2.13061132 |
| 36 | Progressive inability to walk (HP:0002505) | 2.08623620 |
| 37 | Type I transferrin isoform profile (HP:0003642) | 2.06753604 |
| 38 | Respiratory distress (HP:0002098) | 2.06057780 |
| 39 | Intestinal atresia (HP:0011100) | 2.05000083 |
| 40 | Cortical dysplasia (HP:0002539) | 2.04829135 |
| 41 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.00711215 |
| 42 | Cutaneous melanoma (HP:0012056) | 16.0176276 |
| 43 | Hyperkalemia (HP:0002153) | 1.99469365 |
| 44 | Carpal bone hypoplasia (HP:0001498) | 1.99037059 |
| 45 | Irregular vertebral endplates (HP:0003301) | 1.98990960 |
| 46 | Exostoses (HP:0100777) | 1.98279135 |
| 47 | Obsessive-compulsive behavior (HP:0000722) | 1.97184245 |
| 48 | Abnormal trabecular bone morphology (HP:0100671) | 1.94635258 |
| 49 | Hyperammonemia (HP:0001987) | 1.92082035 |
| 50 | Viral hepatitis (HP:0006562) | 1.89909048 |
| 51 | Abnormality of glycolysis (HP:0004366) | 1.89443231 |
| 52 | Abnormality of the parathyroid morphology (HP:0011766) | 1.87827756 |
| 53 | Hyperacusis (HP:0010780) | 1.86584827 |
| 54 | Rhabdomyolysis (HP:0003201) | 1.83133231 |
| 55 | Increased hepatocellular lipid droplets (HP:0006565) | 1.81905779 |
| 56 | Craniofacial dystonia (HP:0012179) | 1.80998291 |
| 57 | Achilles tendon contracture (HP:0001771) | 1.79889907 |
| 58 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.78444918 |
| 59 | Abnormal protein glycosylation (HP:0012346) | 1.78444918 |
| 60 | Abnormal glycosylation (HP:0012345) | 1.78444918 |
| 61 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.78444918 |
| 62 | Abnormality of the line of Schwalbe (HP:0008048) | 1.77708296 |
| 63 | Incomplete penetrance (HP:0003829) | 1.77630679 |
| 64 | Insomnia (HP:0100785) | 1.75749130 |
| 65 | Large eyes (HP:0001090) | 1.73221172 |
| 66 | Hypokinesia (HP:0002375) | 1.72735485 |
| 67 | Abnormality of the Achilles tendon (HP:0005109) | 1.71006058 |
| 68 | Increased serum pyruvate (HP:0003542) | 1.70652623 |
| 69 | Natal tooth (HP:0000695) | 1.69847638 |
| 70 | Increased nuchal translucency (HP:0010880) | 1.69306629 |
| 71 | Lipid accumulation in hepatocytes (HP:0006561) | 1.69129415 |
| 72 | Short femoral neck (HP:0100864) | 1.69024950 |
| 73 | Focal dystonia (HP:0004373) | 1.68787939 |
| 74 | Sparse scalp hair (HP:0002209) | 1.68745419 |
| 75 | Septate vagina (HP:0001153) | 1.68642732 |
| 76 | Patellar aplasia (HP:0006443) | 1.67806856 |
| 77 | Long palpebral fissure (HP:0000637) | 1.67246051 |
| 78 | Congenital glaucoma (HP:0001087) | 1.67044752 |
| 79 | Overlapping toe (HP:0001845) | 1.65557608 |
| 80 | Abnormality of vitamin metabolism (HP:0100508) | 1.64990917 |
| 81 | Pancytopenia (HP:0001876) | 1.64889564 |
| 82 | Increased intramyocellular lipid droplets (HP:0012240) | 1.64847099 |
| 83 | Abnormality of serum amino acid levels (HP:0003112) | 1.64398497 |
| 84 | Gastrointestinal stroma tumor (HP:0100723) | 1.61026386 |
| 85 | Corneal erosion (HP:0200020) | 1.59811028 |
| 86 | Abnormality of the vertebral endplates (HP:0005106) | 1.59667998 |
| 87 | Breast hypoplasia (HP:0003187) | 1.58964423 |
| 88 | Renal Fanconi syndrome (HP:0001994) | 1.58892724 |
| 89 | Supernumerary nipples (HP:0002558) | 1.57744813 |
| 90 | Abnormal epiphyseal ossification (HP:0010656) | 1.57401054 |
| 91 | Neurodegeneration (HP:0002180) | 1.57348341 |
| 92 | Hepatitis (HP:0012115) | 1.55079506 |
| 93 | Progressive microcephaly (HP:0000253) | 1.54619970 |
| 94 | Agammaglobulinemia (HP:0004432) | 1.54446622 |
| 95 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.54101072 |
| 96 | Diminished movement (HP:0002374) | 1.53862867 |
| 97 | Bicornuate uterus (HP:0000813) | 1.53440938 |
| 98 | Upper limb muscle weakness (HP:0003484) | 1.53302090 |
| 99 | Progressive hearing impairment (HP:0001730) | 1.52691069 |
| 100 | Overriding aorta (HP:0002623) | 1.52208607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K10 | 3.63830292 |
| 2 | MAP3K13 | 3.41154005 |
| 3 | BCKDK | 3.28526453 |
| 4 | TLK1 | 3.22233739 |
| 5 | VRK1 | 3.01128213 |
| 6 | ICK | 2.75501268 |
| 7 | FRK | 2.73580993 |
| 8 | EPHB2 | 2.51740587 |
| 9 | TSSK6 | 2.48721110 |
| 10 | ZAK | 2.29694122 |
| 11 | FGFR2 | 2.17750526 |
| 12 | CDC7 | 2.11724834 |
| 13 | NEK9 | 2.11045949 |
| 14 | PBK | 2.01399727 |
| 15 | SMG1 | 1.93339698 |
| 16 | CDK12 | 1.83111355 |
| 17 | MAPK13 | 1.81530747 |
| 18 | MARK1 | 1.79469885 |
| 19 | CSNK1G3 | 1.74038629 |
| 20 | VRK2 | 1.66497200 |
| 21 | AURKA | 1.64639927 |
| 22 | DYRK3 | 1.63762807 |
| 23 | MAP3K14 | 1.59242008 |
| 24 | DYRK2 | 1.58381456 |
| 25 | BCR | 1.56846801 |
| 26 | TRIB3 | 1.46915086 |
| 27 | WNK4 | 1.46226651 |
| 28 | CSNK1A1L | 1.43626283 |
| 29 | TRIM28 | 1.40543496 |
| 30 | CSNK1G2 | 1.26740451 |
| 31 | NEK2 | 1.20589159 |
| 32 | PRKD2 | 1.18542635 |
| 33 | PASK | 1.16029900 |
| 34 | EEF2K | 1.15680002 |
| 35 | DAPK3 | 1.14245651 |
| 36 | MAPKAPK5 | 1.13064913 |
| 37 | EIF2AK1 | 1.11913950 |
| 38 | PIM2 | 1.09844928 |
| 39 | MAP2K7 | 1.09304664 |
| 40 | CDK7 | 1.09220309 |
| 41 | LATS2 | 1.04994178 |
| 42 | PLK1 | 1.02962312 |
| 43 | RPS6KA5 | 1.02685841 |
| 44 | SIK1 | 1.01134083 |
| 45 | SRPK1 | 0.98223475 |
| 46 | IRAK3 | 0.97457013 |
| 47 | MAP3K7 | 0.95319490 |
| 48 | PRKD3 | 0.95201346 |
| 49 | PLK3 | 0.94510942 |
| 50 | LRRK2 | 0.93818277 |
| 51 | MST1R | 0.89837281 |
| 52 | TESK1 | 0.89427364 |
| 53 | IRAK2 | 0.88671901 |
| 54 | CSNK1G1 | 0.87230169 |
| 55 | PKN1 | 0.84340765 |
| 56 | IKBKB | 0.81174806 |
| 57 | WNK1 | 0.79915178 |
| 58 | CHUK | 0.72720491 |
| 59 | MAPKAPK3 | 0.70255538 |
| 60 | PRKCZ | 0.69880047 |
| 61 | STK16 | 0.69062729 |
| 62 | DYRK1B | 0.68925004 |
| 63 | SIK3 | 0.68074498 |
| 64 | ATR | 0.66254161 |
| 65 | ILK | 0.65333811 |
| 66 | SIK2 | 0.61269263 |
| 67 | CHEK2 | 0.60809334 |
| 68 | MAPK15 | 0.58759825 |
| 69 | BUB1 | 0.58747756 |
| 70 | AURKB | 0.56584274 |
| 71 | CSNK1A1 | 0.56299343 |
| 72 | STK4 | 0.55350255 |
| 73 | EPHA2 | 0.55144718 |
| 74 | UHMK1 | 0.53645810 |
| 75 | TGFBR1 | 0.52252161 |
| 76 | MET | 0.51708643 |
| 77 | TAOK2 | 0.49286036 |
| 78 | NEK1 | 0.48752107 |
| 79 | CDK14 | 0.48512386 |
| 80 | NTRK1 | 0.48150621 |
| 81 | MAPK4 | 0.46457774 |
| 82 | CDK18 | 0.43454807 |
| 83 | MAP3K11 | 0.40985699 |
| 84 | TAOK1 | 0.40602009 |
| 85 | WEE1 | 0.40454702 |
| 86 | CDK15 | 0.40133508 |
| 87 | ROCK2 | 0.39780802 |
| 88 | SGK1 | 0.39703836 |
| 89 | RPS6KA4 | 0.39071199 |
| 90 | CDK11A | 0.36676548 |
| 91 | MTOR | 0.36265662 |
| 92 | ROCK1 | 0.35531530 |
| 93 | NME2 | 0.34992531 |
| 94 | IRAK4 | 0.34847453 |
| 95 | TAF1 | 0.34062096 |
| 96 | CSNK1D | 0.34037492 |
| 97 | PRKCQ | 0.33376731 |
| 98 | ADRBK1 | 0.33194555 |
| 99 | NTRK2 | 0.32987814 |
| 100 | PKN2 | 0.31354631 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 5.08397200 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.01770952 |
| 3 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 3.98433057 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.49175799 |
| 5 | Alcoholism_Homo sapiens_hsa05034 | 3.38778561 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.05455054 |
| 7 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.99232547 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.90394757 |
| 9 | DNA replication_Homo sapiens_hsa03030 | 2.77124549 |
| 10 | Spliceosome_Homo sapiens_hsa03040 | 2.47222623 |
| 11 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.44228759 |
| 12 | Sulfur relay system_Homo sapiens_hsa04122 | 2.37289357 |
| 13 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.27533178 |
| 14 | Basal transcription factors_Homo sapiens_hsa03022 | 1.95704396 |
| 15 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.64657708 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.63435271 |
| 17 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.62077659 |
| 18 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.57909845 |
| 19 | Ribosome_Homo sapiens_hsa03010 | 1.40964030 |
| 20 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.37503259 |
| 21 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.37212539 |
| 22 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.34279113 |
| 23 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.31102427 |
| 24 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.28848092 |
| 25 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.28435029 |
| 26 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.28292914 |
| 27 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.27096539 |
| 28 | Proteasome_Homo sapiens_hsa03050 | 1.24683573 |
| 29 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.23231249 |
| 30 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.21209836 |
| 31 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.19911095 |
| 32 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.14475387 |
| 33 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.97228276 |
| 34 | Peroxisome_Homo sapiens_hsa04146 | 0.96856757 |
| 35 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.93430639 |
| 36 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.92759748 |
| 37 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.91257749 |
| 38 | RNA degradation_Homo sapiens_hsa03018 | 0.88428234 |
| 39 | Cell cycle_Homo sapiens_hsa04110 | 0.85139697 |
| 40 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.81384370 |
| 41 | Mismatch repair_Homo sapiens_hsa03430 | 0.79358958 |
| 42 | Parkinsons disease_Homo sapiens_hsa05012 | 0.78736468 |
| 43 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.78630767 |
| 44 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76328962 |
| 45 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.75881862 |
| 46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71919695 |
| 47 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.71415508 |
| 48 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70723683 |
| 49 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.70093777 |
| 50 | Endometrial cancer_Homo sapiens_hsa05213 | 0.69913149 |
| 51 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67729365 |
| 52 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67581686 |
| 53 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.66840958 |
| 54 | Homologous recombination_Homo sapiens_hsa03440 | 0.65590711 |
| 55 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.64758023 |
| 56 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.61327322 |
| 57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.59575396 |
| 58 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.59156556 |
| 59 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.59029119 |
| 60 | RNA polymerase_Homo sapiens_hsa03020 | 0.58740950 |
| 61 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.56866267 |
| 62 | Carbon metabolism_Homo sapiens_hsa01200 | 0.54116549 |
| 63 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.53010086 |
| 64 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.52874699 |
| 65 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52429190 |
| 66 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.51413459 |
| 67 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.51066625 |
| 68 | Axon guidance_Homo sapiens_hsa04360 | 0.51000137 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49542999 |
| 70 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.49402171 |
| 71 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.49286883 |
| 72 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.48590639 |
| 73 | RNA transport_Homo sapiens_hsa03013 | 0.48166951 |
| 74 | Cocaine addiction_Homo sapiens_hsa05030 | 0.47304456 |
| 75 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.46994805 |
| 76 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.45847041 |
| 77 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.45024140 |
| 78 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.44502661 |
| 79 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42313789 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.40084743 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39181755 |
| 82 | Shigellosis_Homo sapiens_hsa05131 | 0.39161266 |
| 83 | Huntingtons disease_Homo sapiens_hsa05016 | 0.38619311 |
| 84 | Alzheimers disease_Homo sapiens_hsa05010 | 0.37573487 |
| 85 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37246968 |
| 86 | Bladder cancer_Homo sapiens_hsa05219 | 0.35693577 |
| 87 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.34216346 |
| 88 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.32458398 |
| 89 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.32337069 |
| 90 | Apoptosis_Homo sapiens_hsa04210 | 0.28083913 |
| 91 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.25762778 |
| 92 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.25340453 |
| 93 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.24852436 |
| 94 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.24052299 |
| 95 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.22859844 |
| 96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.21794748 |
| 97 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.21293731 |
| 98 | HTLV-I infection_Homo sapiens_hsa05166 | 0.20930149 |
| 99 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.20820507 |
| 100 | Purine metabolism_Homo sapiens_hsa00230 | 0.20734460 |

